Updated: Aug 27, 2009
Acalculous cholecystitis is a severe illness that is a complication of various other medical or surgical conditions. Duncan first recognized it in 1844 when a fatal case of acalculous cholecystitis complicating an incarcerated hernia was reported. The condition causes approximately 5-10% of all cases of acute cholecystitis and is usually associated with more serious morbidity and higher mortality rates than calculous cholecystitis. It is most commonly observed in the setting of very ill patients (eg, on mechanical ventilation, with sepsis or severe burn injuries,1 after severe trauma2 ). In addition, acalculous cholecystitis is associated with a higher incidence of gangrene and perforation compared to calculous disease.
The usual finding on imaging studies is a distended acalculous gallbladder with thickened walls (>3-4 mm) with or without pericholecystic fluid. Acalculous cholecystitis can be observed in patients with human immunodeficiency virus (HIV) infection, although it is a late manifestation of this disease. Acalculous cholecystitis can also be found in patients on total parenteral nutrition (TPN), typically those on TPN for more than 3 months.
The main cause of this illness is thought to be due to bile stasis and increased lithogenicity of bile. Critically ill patients are more predisposed because of increased bile viscosity due to fever and dehydration and because of prolonged absence of oral feeding resulting in a decrease or absence of cholecystokinin-induced gallbladder contraction. Gallbladder wall ischemia that occurs because of a low-flow state due to fever, dehydration, or heart failure may also play a role in the pathogenesis of acalculous cholecystitis.
Acalculous cholecystitis comprises approximately 5-10% of all cases of acute cholecystitis.
The mortality and morbidity rates associated with acalculous cholecystitis can be high; the illness is frequently observed in patients with sepsis or other serious conditions. The reported mortality range is 10-50% for acalculous cholecystitis as compared to 1% for calculous cholecystitis.
It can occur in all races.
Acalculous cholecystitis has a slight male predominance, unlike calculous cholecystitis, which has a female predominance.
The condition can occur in persons of any age, although a higher frequency is reported in persons in their fourth and eighth decades of life.
History findings are of limited value. Often, many patients are very ill (possibly on mechanical ventilation) and cannot communicate a history or symptoms.
Physical examination may reveal fever and right upper quadrant tenderness.
The main cause of acalculous cholecystitis is gallbladder stasis with resulting stagnant bile. This is observed most commonly in patients with sepsis, patients in intensive care units, patients on long-term TPN, patients with diabetes (occasionally), or other patients with gallbladder dysmotility. The condition has also been reported during pregnancy, as a complication of hepatitis A.3 It has been rarely reported in children, also as a complication of hepatitis A,4 with a favorable course with conservative treatment.
Sepsis with biliary tract infection
AIDS cholangiopathy
TPN-associated liver disease
When the diagnosis of acalculous cholecystitis is established, immediate intervention is indicated because of the high risk of rapid deterioration and gallbladder perforation.
In patients with acalculous cholecystitis who are high-risk surgical candidates (ie, end-stage liver disease), endoscopic gallbladder stent placement has been reported as an effective palliative treatment. This involves placement of a double pigtail stent between the gallbladder and the duodenum during endoscopic retrograde cholangiopancreatography (ERCP). However, the definitive treatment of acalculous cholecystitis is cholecystectomy for patients who are able to tolerate surgery.
In surgical candidates, open or laparoscopic cholecystectomy is indicated.5 In patients who are not surgical candidates, percutaneous cholecystostomy may be performed in the radiology suite. Catheters are usually removed after approximately 3 weeks in critically ill patients with acalculous cholecystitis who have undergone percutaneous cholecystostomy. This allows for the development of a mature track from the skin to the gallbladder.
Patients in the acute stage of acalculous cholecystitis should receive nothing by mouth. Hydration with intravenous fluids should be provided.
Administer broad-spectrum antibiotics for enteric and biliary pathogen coverage. Definitive treatment is cholecystectomy in patients who are surgical candidates or cholecystostomy in patients who are not surgical candidates.
Theodorou P, Maurer CA, Spanholtz TA, Phan TQ, Amini P, Perbix W, et al. Acalculous cholecystitis in severely burned patients: incidence and predisposing factors. Burns. May 2009;35(3):405-11. [Medline].
Hamp T, Fridrich P, Mauritz W, Hamid L, Pelinka LE. Cholecystitis after trauma. J Trauma. Feb 2009;66(2):400-6. [Medline].
Basar O, Kisacik B, Bozdogan E, et al. An unusual cause of acalculous cholecystitis during pregnancy: hepatitis A virus. Dig Dis Sci. Aug 2005;50(8):1532. [Medline].
Fuoti M, Pinotti M, Miceli V, et al. [Acute acalculous cholecystitis as a complication of hepatitis A: report of 2 pediatric cases] [Italian]. Pediatr Med Chir. Mar-Apr 2008;30(2):102-5. [Medline].
Casillas RA, Yegiyants S, Collins JC. Early laparoscopic cholecystectomy is the preferred management of acute cholecystitis. Arch Surg. Jun 2008;143(6):533-7. [Medline].
Babb RR. Acute acalculous cholecystitis. A review. J Clin Gastroenterol. Oct 1992;15(3):238-41. [Medline].
Barie PS, Fischer E. Acute acalculous cholecystitis. J Am Coll Surg. Feb 1995;180(2):232-44. [Medline].
Boland G, Lee MJ, Mueller PR. Acute cholecystitis in the intensive care unit. New Horiz. May 1993;1(2):246-60. [Medline].
Boland GW, Lee MJ, Dawson SL, Mueller PR. Percutaneous cholecystostomy for acute acalculous cholecystitis in a critically ill patient. AJR Am J Roentgenol. Apr 1993;160(4):871-4. [Medline].
Chung SC. Acute acalculous cholecystitis. A reminder that this condition may appear in a primary care practice. Postgrad Med. Sep 1995;98(3):199-200, 203-4. [Medline].
Conway JD, Russo MW, Shrestha R. Endoscopic stent insertion into the gallbladder for symptomatic gallbladder disease in patients with end-stage liver disease. Gastrointest Endosc. Jan 2005;61(1):32-6. [Medline].
Fisher RL. Hepatobiliary abnormalities associated with total parenteral nutrition. Gastroenterol Clin North Am. Sep 1989;18(3):645-66. [Medline].
Hasse C, Zielke A, Nies C, et al. Influence of ceruletid on gallbladder contraction: a possible prophylaxis of acute acalculous cholecystitis in intensive care patients?. Digestion. 1995;56(5):389-94. [Medline].
Hatada T, Kobayashi H, Tanigawa A, et al. Acute acalculous cholecystitis in a patient on total parenteral nutrition: case report and review of the Japanese literature. Hepatogastroenterology. Jul-Aug 1999;46(28):2208-11. [Medline].
Kageoka M, Watanabe F, Maruyama Y, et al. Long-term prognosis of patients after endoscopic sphincterotomy for choledocholithiasis. Dig Endosc. Jul 2009;21(3):170-5. [Medline].
Lameris JS, van Overhagen H. Imaging and intervention in patients with acute right upper quadrant disease. Baillieres Clin Gastroenterol. Mar 1995;9(1):21-36. [Medline].
Lee SW, Yang SS, Chang CS, Yeh HJ. Impact of the Tokyo guidelines on the management of patients with acute calculous cholecystitis. J Gastroenterol Hepatol. Aug 3 2009;epub ahead of print. [Medline].
Lillemoe KD. Surgical treatment of biliary tract infections. Am Surg. Feb 2000;66(2):138-44. [Medline].
Merrell RC, Miller-Crotchett P, Lowry P. Gallbladder response to enteral lipids in injured patients. Arch Surg. Mar 1989;124(3):301-2. [Medline].
Nash JA, Cohen SA. Gallbladder and biliary tract disease in AIDS. Gastroenterol Clin North Am. Jun 1997;26(2):323-35. [Medline].
Owen CC, Bilhartz LE. Gallbladder polyps, cholesterolosis, adenomyomatosis, and acute acalculous cholecystitis. Semin Gastrointest Dis. Oct 2003;14(4):178-88. [Medline].
Schwesinger WH, Diehl AK. Changing indications for laparoscopic cholecystectomy. Stones without symptoms and symptoms without stones. Surg Clin North Am. Jun 1996;76(3):493-504. [Medline].
acalculous cholecystitis, acute cholecystitis, cholecystitis, gallbladder inflammation, inflammation of the gallbladder, gallbladder pain, total parenteral nutrition, TPN, bile stasis, gallbladder stasis, stagnant bile, gallbladder dysmotility, sepsis with biliary tract infection, AIDS cholangiopathy, TPN-associated liver disease, cholecystectomy, percutaneous cholecystostomy
Homayoun Shojamanesh, MD, Former Fellow, Digestive Diseases Branch, National Institutes of Health
Homayoun Shojamanesh, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.
Praveen K Roy, MD, Comments and Criticisms Editor, Cochrane Colorectal Cancer Group
Praveen K Roy, MD is a member of the following medical societies: American College of Gastroenterology, American Gastroenterological Association, and Canadian Association of Gastroenterology
Disclosure: Nothing to disclose.
Marco G Patti, MD, Professor of Surgery, Director, Center for Esophageal Diseases, University of Chicago Pritzker School of Medicine
Marco G Patti, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Surgeons, American Gastroenterological Association, American Medical Association, American Surgical Association, Association for Academic Surgery, Pan-Pacific Surgical Association, Society for Surgery of the Alimentary Tract, Society of American Gastrointestinal and Endoscopic Surgeons, Southwestern Surgical Congress, and Western Surgical Association
Disclosure: Nothing to disclose.
Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment
Michael A Grosso, MD, Consulting Staff, Department of Cardiothoracic Surgery, St Francis Hospital
Michael A Grosso, MD is a member of the following medical societies: American College of Surgeons, Society of Thoracic Surgeons, and Society of University Surgeons
Disclosure: Nothing to disclose.
Paolo Zamboni, MD, Professor of Surgery, Chief of Day Surgery Unit, Chair of Vascular Diseases Center, University of Ferrara, Italy
Paolo Zamboni, MD is a member of the following medical societies: American Venous Forum and New York Academy of Sciences
Disclosure: Nothing to disclose.
John Geibel, MD, DSc, MA, Vice Chairman, Professor, Department of Surgery, Section of Gastrointestinal Medicine and Department of Cellular and Molecular Physiology, Yale University School of Medicine; Director of Surgical Research, Department of Surgery, Yale-New Haven Hospital
John Geibel, MD, DSc, MA is a member of the following medical societies: American Gastroenterological Association, American Physiological Society, American Society of Nephrology, Association for Academic Surgery, International Society of Nephrology, New York Academy of Sciences, and Society for Surgery of the Alimentary Tract
Disclosure: AMGEN Royalty Other
Related eMedicine Topics
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)